Position in MRK
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,261,998
+$86,164 QoQ
Shares Held
9,821
+0.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,930
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAPITAL ADVISORS INC/OK holds $173,896,300 across 10 Drug Manufacturers - General names. MRK ranks #6 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
447,129 | $112,515,541 | |
| 2 | PFE |
Pfizer Inc
|
1,770,761 | $42,639,924 | |
| 3 | LLY |
ELI LILLY & Co
|
6,287 | $7,540,817 | |
| 4 | JNJ |
Johnson & Johnson
|
22,507 | $5,716,102 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
24,641 | $1,419,814 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
9,821 | $1,261,998 | |
| 7 | NVO |
Novo Nordisk A S
|
25,516 | $1,223,237 | |
| 8 | AMGN |
Amgen Inc
|
2,255 | $816,580 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,261,998 | 9,821 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $1,175,834 | 9,775 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,048,179 | 9,958 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $764,938 | 9,114 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $499,341 | 6,308 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $609,649 | 6,792 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $731,476 | 7,353 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $838,981 | 7,388 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $930,480 | 7,516 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $965,214 | 7,315 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $763,140 | 7,000 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $731,665 | 7,107 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $824,807 | 7,148 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $709,940 | 6,673 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $845,660 | 7,622 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $661,659 | 7,683 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $711,126 | 7,800 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $718,840 | 8,761 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $781,498 | 10,197 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $502,410 | 6,689 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $520,670 | 6,695 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $539,784 | 7,002 | Shares | Sole | 2021-05-25 | |
| 2020-12-31 | $534,071 | 6,529 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $510,723 | 6,157 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $457,871 | 5,921 | Shares | Sole | 2020-09-02 | |
| 2020-03-31 | $439,096 | 5,707 | Shares | Sole | 2020-05-21 | |
| No filing history on record for this holder in this stock. | ||||||